Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degenerations.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01749891
What this trial is testing

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Allegro Ophthalmics, LLC 25
Post-approval studies (Phase 4)Study completedNCT00504959
What this trial is testing

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization (CNV)Secondary to Age-related Macular Degeneration (AMD)
Novartis 234
Not applicableUnknownNCT04882956
What this trial is testing

BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration

Who this might be right for
Macula Lutea Degeneration
Benha University 40
Post-approval studies (Phase 4)Study completedNCT02581891
What this trial is testing

Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye

Who this might be right for
Macular Degeneration
Bayer 287
Early research (Phase 1)Study completedNCT05903794
What this trial is testing

EXG102-031 in Patients With wAMD (Everest)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Exegenesis Bio 12
Not applicableStudy completedNCT02090751
What this trial is testing

Development of a Device to Measure Dark Adaptation

Who this might be right for
Macular DegenerationAge-Related Macular Degeneration
University of Manchester 40
Not applicableLooking for participantsNCT04739319
What this trial is testing

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

Who this might be right for
Age Related Macular DegenerationGeographic AtrophyAMD+1 more
Center for Eye Research Australia 2,500
Not applicableUnknownNCT01626339
What this trial is testing

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

Who this might be right for
Age Related Macular Degeneration
University of Malaya 30
Early research (Phase 1)Study completedNCT05345769
What this trial is testing

Safety and Efficacy of AM712 in Patients with NAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
AffaMed Therapeutics Limited 21
Post-approval studies (Phase 4)UnknownNCT01657669
What this trial is testing

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Who this might be right for
Age Related Macular Degeneration
Retina Research Institute, LLC 22
Large-scale testing (Phase 3)Active Not RecruitingNCT06373731
What this trial is testing

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age Related Macular Degeneration (ARMD)
Stealth BioTherapeutics Inc. 313
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT03479372
What this trial is testing

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
PanOptica, Inc. 51
Not applicableStudy completedNCT05834075
What this trial is testing

A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India

Who this might be right for
Neurovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 63
Not applicableNot Yet RecruitingNCT07249307
What this trial is testing

High-throughput Large-model-based AI-assisted Diagnosis Using OCT

Who this might be right for
Diabetic Retinopathy (DR)Retinal Vein Occlusion (RVO)Age-Related Macular Degeneration (AMD)+2 more
Peking Union Medical College Hospital 2,000
Not applicableStudy completedNCT03290794
What this trial is testing

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 100
Not applicableStudy completedNCT00379795
What this trial is testing

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Who this might be right for
Choroidal Neovascularization, Age-related Macular Degeneration
Genentech, Inc. 853
Early research (Phase 1)Ended earlyNCT04594681
What this trial is testing

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Healthy VolunteersWet Age-related Macular Degeneration
Kyowa Kirin Co., Ltd. 116
Not applicableStudy completedNCT03946085
What this trial is testing

Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal DrusenAge-related Macular DegenerationMacular Degeneration
Guardion Health Sciences, Inc. 79
Not applicableNot Yet RecruitingNCT07409389
What this trial is testing

Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration

Who this might be right for
AMD - Age-Related Macular Degeneration
The Hong Kong Polytechnic University 94
Next Page